Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papio | 21 | 2023 | 78 | 1.930 |
Why?
|
| Zika Virus | 5 | 2022 | 28 | 1.810 |
Why?
|
| Zika Virus Infection | 5 | 2022 | 28 | 1.810 |
Why?
|
| Monkey Diseases | 6 | 2020 | 16 | 1.540 |
Why?
|
| Antibodies, Viral | 10 | 2023 | 74 | 1.480 |
Why?
|
| Viremia | 4 | 2019 | 16 | 1.370 |
Why?
|
| Whooping Cough | 8 | 2023 | 15 | 1.240 |
Why?
|
| West Nile virus | 4 | 2010 | 20 | 0.910 |
Why?
|
| Papio anubis | 7 | 2022 | 40 | 0.900 |
Why?
|
| Semen | 2 | 2020 | 27 | 0.850 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2021 | 12 | 0.790 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 1391 | 0.760 |
Why?
|
| Animals | 37 | 2023 | 9916 | 0.740 |
Why?
|
| Bordetella pertussis | 7 | 2023 | 8 | 0.720 |
Why?
|
| Retroviridae Infections | 1 | 2019 | 1 | 0.700 |
Why?
|
| Testis | 1 | 2019 | 35 | 0.690 |
Why?
|
| Spermatozoa | 1 | 2019 | 28 | 0.680 |
Why?
|
| RNA, Viral | 4 | 2020 | 67 | 0.620 |
Why?
|
| West Nile Fever | 4 | 2010 | 15 | 0.550 |
Why?
|
| Glycoproteins | 2 | 2019 | 118 | 0.530 |
Why?
|
| Viral Proteins | 4 | 2023 | 62 | 0.490 |
Why?
|
| Pertussis Vaccine | 4 | 2023 | 6 | 0.470 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 3 | 2021 | 9 | 0.470 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 322 | 0.460 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2013 | 3 | 0.440 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 44 | 0.410 |
Why?
|
| Immunoglobulin G | 6 | 2022 | 266 | 0.410 |
Why?
|
| Viral Vaccines | 2 | 2011 | 11 | 0.410 |
Why?
|
| Rift Valley Fever | 1 | 2011 | 1 | 0.390 |
Why?
|
| Rift Valley fever virus | 1 | 2011 | 1 | 0.390 |
Why?
|
| Vaccinia virus | 1 | 2011 | 6 | 0.390 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 262 | 0.380 |
Why?
|
| Virology | 1 | 2010 | 4 | 0.360 |
Why?
|
| Genome, Viral | 1 | 2010 | 28 | 0.360 |
Why?
|
| Schistosomiasis | 2 | 2020 | 9 | 0.330 |
Why?
|
| Vaccines | 2 | 2020 | 29 | 0.330 |
Why?
|
| Virus Replication | 3 | 2021 | 55 | 0.320 |
Why?
|
| Antibodies, Bacterial | 5 | 2023 | 100 | 0.310 |
Why?
|
| Pertussis Toxin | 2 | 2020 | 7 | 0.310 |
Why?
|
| Antibodies, Neutralizing | 4 | 2021 | 69 | 0.300 |
Why?
|
| Schistosoma mansoni | 4 | 2020 | 12 | 0.290 |
Why?
|
| Vaccination | 5 | 2021 | 164 | 0.280 |
Why?
|
| Male | 12 | 2021 | 12817 | 0.280 |
Why?
|
| Female | 16 | 2022 | 14403 | 0.270 |
Why?
|
| Transcription, Genetic | 4 | 2018 | 398 | 0.270 |
Why?
|
| Lung | 3 | 2023 | 346 | 0.260 |
Why?
|
| DNA, Viral | 2 | 2008 | 50 | 0.260 |
Why?
|
| Methylene Blue | 1 | 2005 | 8 | 0.260 |
Why?
|
| Humans | 21 | 2023 | 26746 | 0.250 |
Why?
|
| Herpesviridae | 1 | 2005 | 2 | 0.250 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2021 | 9 | 0.240 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 20 | 0.240 |
Why?
|
| Organic Chemicals | 1 | 2004 | 14 | 0.230 |
Why?
|
| gamma-Globulins | 1 | 2023 | 2 | 0.230 |
Why?
|
| Squalene | 1 | 2023 | 2 | 0.230 |
Why?
|
| Melphalan | 1 | 2023 | 6 | 0.230 |
Why?
|
| Polysorbates | 1 | 2023 | 5 | 0.230 |
Why?
|
| Acetylglucosamine | 1 | 2023 | 15 | 0.230 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 87 | 0.230 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 37 | 0.230 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 48 | 0.220 |
Why?
|
| Antibodies, Helminth | 2 | 2020 | 9 | 0.220 |
Why?
|
| Antigens, Helminth | 2 | 2020 | 10 | 0.220 |
Why?
|
| Mice | 10 | 2023 | 4387 | 0.220 |
Why?
|
| Mucous Membrane | 2 | 2023 | 26 | 0.210 |
Why?
|
| Coinfection | 2 | 2020 | 14 | 0.210 |
Why?
|
| Schistosomiasis mansoni | 2 | 2020 | 7 | 0.200 |
Why?
|
| Liver | 2 | 2021 | 414 | 0.190 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 17 | 0.190 |
Why?
|
| Capillaries | 1 | 2021 | 32 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 36 | 0.190 |
Why?
|
| Bronchi | 1 | 2021 | 38 | 0.190 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 51 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 64 | 0.190 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 109 | 0.190 |
Why?
|
| Helminthiasis, Animal | 1 | 2020 | 3 | 0.180 |
Why?
|
| Immunization, Passive | 1 | 2020 | 20 | 0.180 |
Why?
|
| Endothelial Cells | 2 | 2021 | 324 | 0.180 |
Why?
|
| Trichuriasis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2020 | 3 | 0.180 |
Why?
|
| Immunoglobulin M | 2 | 2018 | 28 | 0.180 |
Why?
|
| Blood-Testis Barrier | 1 | 2019 | 3 | 0.180 |
Why?
|
| Vagina | 1 | 2020 | 42 | 0.180 |
Why?
|
| Betaretrovirus | 1 | 2019 | 1 | 0.170 |
Why?
|
| Viral Fusion Proteins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Spermatogenesis | 1 | 2019 | 11 | 0.170 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 37 | 0.170 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 46 | 0.170 |
Why?
|
| DNA Primers | 3 | 2010 | 143 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 73 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2021 | 204 | 0.170 |
Why?
|
| Herpesvirus 8, Human | 3 | 2004 | 12 | 0.160 |
Why?
|
| Stem Cells | 1 | 2019 | 113 | 0.160 |
Why?
|
| Protozoan Vaccines | 1 | 2018 | 5 | 0.160 |
Why?
|
| Brazil | 1 | 2018 | 21 | 0.160 |
Why?
|
| Praziquantel | 1 | 2018 | 2 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 244 | 0.160 |
Why?
|
| Vero Cells | 2 | 2011 | 12 | 0.160 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2018 | 4 | 0.160 |
Why?
|
| Pregnancy | 5 | 2022 | 1126 | 0.150 |
Why?
|
| Hyperventilation | 1 | 2017 | 3 | 0.150 |
Why?
|
| Ape Diseases | 1 | 2017 | 4 | 0.150 |
Why?
|
| Apnea | 1 | 2017 | 12 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 133 | 0.150 |
Why?
|
| False Negative Reactions | 2 | 2010 | 24 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 26 | 0.150 |
Why?
|
| Propofol | 1 | 2017 | 10 | 0.150 |
Why?
|
| Anesthetics, Intravenous | 1 | 2017 | 14 | 0.150 |
Why?
|
| Infant | 3 | 2021 | 959 | 0.150 |
Why?
|
| Macrophages | 1 | 2019 | 272 | 0.140 |
Why?
|
| Bordetella bronchiseptica | 1 | 2016 | 4 | 0.140 |
Why?
|
| Bordetella Infections | 1 | 2016 | 4 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 263 | 0.140 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 1034 | 0.130 |
Why?
|
| Base Sequence | 3 | 2008 | 573 | 0.130 |
Why?
|
| Parasite Egg Count | 3 | 2020 | 9 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2015 | 130 | 0.120 |
Why?
|
| Papio cynocephalus | 2 | 2011 | 5 | 0.120 |
Why?
|
| Mice, SCID | 2 | 2011 | 59 | 0.110 |
Why?
|
| Shiga Toxins | 1 | 2013 | 1 | 0.110 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2013 | 1 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 25 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2013 | 28 | 0.110 |
Why?
|
| Species Specificity | 1 | 2013 | 185 | 0.100 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2013 | 81 | 0.100 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 8 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 274 | 0.090 |
Why?
|
| Neutralization Tests | 3 | 2020 | 32 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2011 | 206 | 0.090 |
Why?
|
| Adenylyl Cyclases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2010 | 5 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
| Birds | 1 | 2010 | 21 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2023 | 239 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2010 | 80 | 0.090 |
Why?
|
| Fetus | 2 | 2022 | 76 | 0.090 |
Why?
|
| Placenta | 2 | 2022 | 74 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 163 | 0.090 |
Why?
|
| Glucose | 1 | 2010 | 190 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 363 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2020 | 264 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 437 | 0.070 |
Why?
|
| Herpesviridae Infections | 2 | 2004 | 16 | 0.070 |
Why?
|
| West Nile Virus Vaccines | 1 | 2006 | 2 | 0.070 |
Why?
|
| Sarcoma, Kaposi | 2 | 2003 | 7 | 0.070 |
Why?
|
| Viral Plaque Assay | 1 | 2005 | 4 | 0.060 |
Why?
|
| Sterilization | 1 | 2005 | 8 | 0.060 |
Why?
|
| Blood | 1 | 2005 | 33 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2017 | 163 | 0.060 |
Why?
|
| Antiviral Agents | 2 | 2004 | 103 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 254 | 0.060 |
Why?
|
| Encephalitis Virus, Eastern Equine | 1 | 2005 | 1 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2005 | 73 | 0.060 |
Why?
|
| Light | 1 | 2005 | 117 | 0.060 |
Why?
|
| Laminin | 1 | 2004 | 21 | 0.060 |
Why?
|
| Lymphoma | 1 | 2004 | 22 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2004 | 37 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2004 | 50 | 0.060 |
Why?
|
| Benzothiazoles | 1 | 2004 | 5 | 0.060 |
Why?
|
| Diamines | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2021 | 967 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2004 | 27 | 0.060 |
Why?
|
| Quinolines | 1 | 2004 | 25 | 0.060 |
Why?
|
| Biopolymers | 1 | 2023 | 14 | 0.060 |
Why?
|
| Point Mutation | 1 | 2004 | 60 | 0.060 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 62 | 0.060 |
Why?
|
| Rhadinovirus | 1 | 2003 | 3 | 0.060 |
Why?
|
| Software | 1 | 2005 | 121 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.060 |
Why?
|
| Inflammation | 2 | 2021 | 592 | 0.060 |
Why?
|
| Collagen | 1 | 2004 | 147 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 246 | 0.060 |
Why?
|
| Weight Loss | 1 | 2023 | 71 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 4 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 24 | 0.050 |
Why?
|
| Transgenes | 1 | 2002 | 59 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 407 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 487 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2002 | 55 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.050 |
Why?
|
| Cell Death | 1 | 2021 | 110 | 0.050 |
Why?
|
| Interferons | 1 | 2021 | 68 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2001 | 11 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 12 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2021 | 6 | 0.050 |
Why?
|
| Virus Latency | 1 | 2001 | 9 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2021 | 121 | 0.050 |
Why?
|
| Trichuris | 1 | 2020 | 5 | 0.040 |
Why?
|
| Animal Diseases | 1 | 2020 | 4 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 24 | 0.040 |
Why?
|
| Granuloma | 1 | 2020 | 17 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 22 | 0.040 |
Why?
|
| Cell Line | 3 | 2010 | 671 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 332 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 272 | 0.040 |
Why?
|
| Microcephaly | 1 | 2019 | 8 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 21 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 435 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2018 | 20 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 245 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2019 | 18 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mothers | 1 | 2019 | 107 | 0.040 |
Why?
|
| Anthelmintics | 1 | 2018 | 4 | 0.040 |
Why?
|
| Transcriptome | 1 | 2020 | 198 | 0.040 |
Why?
|
| Trachea | 1 | 2018 | 25 | 0.040 |
Why?
|
| Bordetella parapertussis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 386 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 6 | 0.040 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 47 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 129 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 5 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 453 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 22 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2018 | 398 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 2016 | 7 | 0.040 |
Why?
|
| Tumor Virus Infections | 2 | 2008 | 14 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2015 | 7 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 159 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 56 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 440 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 748 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 96 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1466 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2021 | 1332 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2143 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 673 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2014 | 8 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 450 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 940 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 693 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 758 | 0.030 |
Why?
|
| Shiga Toxin 1 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Shiga Toxin 2 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Eosinophils | 1 | 2013 | 6 | 0.030 |
Why?
|
| Mesangial Cells | 1 | 2013 | 9 | 0.030 |
Why?
|
| Chemokines | 1 | 2013 | 73 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2262 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 5149 | 0.020 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2010 | 1 | 0.020 |
Why?
|
| Receptors, Glucagon | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cytophotometry | 1 | 2010 | 2 | 0.020 |
Why?
|
| Transfection | 2 | 2002 | 312 | 0.020 |
Why?
|
| Colforsin | 1 | 2010 | 12 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 644 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 661 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2010 | 150 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 187 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 231 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 624 | 0.020 |
Why?
|
| Papio ursinus | 1 | 2008 | 2 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2008 | 2 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2008 | 9 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2008 | 7 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2008 | 47 | 0.020 |
Why?
|
| Polyomavirus Infections | 1 | 2008 | 6 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 446 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 1535 | 0.020 |
Why?
|
| Subrenal Capsule Assay | 1 | 2004 | 5 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 11 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2004 | 7 | 0.020 |
Why?
|
| Abdominal Wall | 1 | 2004 | 9 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 60 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 88 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 153 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2003 | 4 | 0.010 |
Why?
|
| Thymidylate Synthase | 1 | 2003 | 7 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2003 | 9 | 0.010 |
Why?
|
| Viral Load | 1 | 2003 | 30 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 2002 | 20 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 150 | 0.010 |
Why?
|
| Virus Activation | 1 | 2001 | 9 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2001 | 38 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2001 | 23 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 121 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 97 | 0.010 |
Why?
|